Nortis, Inc. – Trademark Portfolio
Entity Type: 03
Nortis, Inc. has 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include NORTIS and PARVIVO. The portfolio includes 5 registered trademarks. Filings span 5 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 42 (Computer & Scientific). This trademark owner is based in Seattle, WA.
2145 N 90th St.
Seattle, WA 98103
Showing of trademarks Trademarks
Trademark Classifications
Nortis, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Frequently Asked Questions
How many trademarks does Nortis, Inc. have?
Nortis, Inc. has 15 U.S. trademarks filed with the USPTO. Of these, 5 registered, 7 abandoned, 3 cancelled.
What trademark classes does Nortis, Inc. file in?
Nortis, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Nortis, Inc.'s most well-known trademarks?
Nortis, Inc.'s registered trademark portfolio includes well-known marks such as NORTIS and PARVIVO. These are among 5 currently registered trademarks in the portfolio.
What is Nortis, Inc.'s trademark registration success rate?
Nortis, Inc. has a 33% trademark registration rate, with 5 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.